Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,820 | 175,530 | 20,525 | 86,508 | 24,930 |
| Marketable Securities | 268,312 | 71,000 | 205,912 | 39,000 | 20,000 |
| TOTAL | $334,643 | $250,942 | $227,690 | $127,075 | $46,325 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 7,720 | 3,724 | 2,943 | 439 | 1,131 |
| TOTAL | $7,720 | $3,724 | $2,943 | $439 | $1,131 |
| Total Assets | $342,363 | $254,666 | $230,633 | $127,514 | $47,456 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,320 | 1,513 | 788 | 1,557 | 1,544 |
| Accrued Expenses | 13,427 | 9,708 | 7,690 | 3,281 | 4,197 |
| TOTAL | $19,131 | $11,550 | $9,060 | $5,203 | $6,390 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 99,293 | 95,324 | 96,755 | 96,398 | 397 |
| TOTAL | $99,293 | $95,324 | $96,755 | $96,398 | $397 |
| Total Liabilities | $118,424 | $106,874 | $105,815 | $101,601 | $6,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,434 | 54,903 | 27,987 | 13,017 | 3,904 |
| Common Shares | 57 | 41 | 28 | 13 | 4 |
| Retained earnings | -674,794 | -580,534 | -507,643 | -455,809 | -260,897 |
| Other shareholders' equity | 163 | 0 | -79 | 0 | 0 |
| TOTAL | $223,939 | $147,792 | $124,818 | $25,913 | $40,669 |
| Total Liabilities And Equity | $342,363 | $254,666 | $230,633 | $127,514 | $47,456 |